Dangawan, Apolinaria .
HRN: 26-54-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2025
CEFTRIAXONE 1G (VIAL)
01/16/2025
01/22/2025
IV
2g
OD
Cap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes